Has Jeffrey Hancock, MD received payments from drug or device companies?

Yes. Drug and device makers reported $20,415 in general payments to Jeffrey Hancock, MD across 1,130 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jeffrey Hancock, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jeffrey Hancock, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jeffrey Hancock, MD

Pediatrics · Rexburg, IDNPI 1265637573

Payments from drug & device makers

$20,415in general payments, 2019–2025

Across 1,130 payments — averaging $18.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$1K
E.r. Squibb & Sons, L.L.C.$1K
Pfizer$1K
Varian Medical Systems, Inc.$1K
Merck$1K
Seagen Inc.$992
plus $13K from 54 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca(2 entities)	71	$1,452
E.r. Squibb & Sons, L.L.C.	97	$1,266
Pfizer	106	$1,202
Varian Medical Systems, Inc.	2	$1,125
Merck	57	$1,019
Seagen Inc.	44	$992
Novartis	64	$987
Incyte Corporation	38	$858
Genentech USA, Inc.	55	$835
Amgen	53	$793
Sanofi	44	$733
Eisai Inc.	42	$700
Johnson & Johnson(2 entities)	35	$658
Daiichi Sankyo Inc.	28	$538
AbbVie	27	$509
Bristol Myers Squibb	20	$452
Bayer	39	$446
Takeda Pharmaceuticals U.S.A., Inc.	16	$392
Lilly USA, LLC	21	$377
Jazz Pharmaceuticals Inc.	16	$375
Astellas Pharma US Inc	15	$259
GSK	15	$252
Tersera Therapeutics LLC	13	$233
Gilead(2 entities)	13	$223
Pharmacyclics LLC, An Abbvie Company	13	$217
EMD Serono, Inc.	11	$217
CSL Behring	12	$200
AVEO Pharmaceuticals, Inc.	5	$161
Rigel Pharmaceuticals, Inc.	10	$161
Puma Biotechnology, Inc.	8	$150
Servier Pharmaceuticals LLC	7	$139
Boehringer Ingelheim	7	$139
Beone Medicines USA, Inc.	4	$123
Karyopharm Therapeutics Inc.	6	$115
Blueprint Medicines Corporation	6	$112
Beigene USA, Inc.	6	$105
Stemline Therapeutics Inc.	5	$101
Myovant Sciences Inc.	6	$99
Sumitomo Pharma America, Inc.	5	$97
EUSA Pharma (US) LLC	5	$92
Exelixis Inc.	5	$88
Genmab U.S., Inc.	4	$88
Dendreon Pharmaceuticals LLC	4	$88
Pharmacosmos Therapeutics Inc.	5	$88
Coherus Oncology, Inc.	4	$77
Clovis Oncology, Inc.	4	$68
Acrotech Biopharma Inc.	4	$66
Ipsen Biopharmaceuticals, Inc	4	$65
Sobi, Inc	3	$62
Pharmaessentia USA Corporation	3	$54
Fennec Pharmaceuticals, Inc.	3	$52
ADC Therapeutics America, Inc.	2	$40
Mirati Therapeutics, Inc.	2	$40
Adaptive Biotechnologies Corporation	2	$39
Springworks Therapeutics, Inc.	2	$39
Morphosys, US Inc.	2	$37
Immunocore Limited	1	$30
G1 Therapeutics, Inc.	2	$28
Iovance Biotherapeutics, Inc.	1	$26
Regeneron Healthcare Solutions, Inc.	2	$26

How this compares

$20,415 in reported general payments places this provider in the 95th percentile of 150 pediatrics providers in Idaho.

See all pediatrics providers in Idaho →

Medicare billing

Part B allowed, 2024

$43,521

Medicare patients

168

Services billed

330

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pediatrics in Rexburg

Jason HymasRexburg$221K
Joseph MooreAmmon$2.4M
Richard AguilarNampa$1.6M
Perry BrownBoise$907K
Laura McDermottEagle$45K
Kelly GraffBuhl$4K
Luna HodgesBoise$3K
Mitchell MoffittTwin Falls$3K
Aimee HastriterBoise$3K
Brandon TaylorMeridian$2K

See the full list for Idaho →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →